🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Oliver W. Press

ORCID: 0000-0002-3147-8037

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma”.

A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma

American Journal of Hematology(2020)10.1002/ajh.25818

N/A

0DataRank · unranked

10 citations

Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Ryan D. Cassaday, Paul S. Martin +8 more

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

UNC Libraries(2020)10.17615/w76e-ms81

N/A

0DataRank · unranked

0 citations

Amanda Axtman, Mark D. Hylarides, Jaideep Shenoi, Shani M. Frayo, Steven I. Park +11 more

Data from Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211

(2023)10.1158/0008-5472.c.6499911.v1

N/A

0DataRank · unranked

0 citations

Dwight Wilbur, Donald K. Hamlin, Monica S. Thakar, Erlinda B. Santos, Darrell R. Fisher +6 more